Sigilon Therapeutics to effect 13-for-1 reverse stock split
eternalcreative/iStock via Getty Images
- Sigilon Therapeutics (NASDAQ:SGTX) said on Monday that it will effect a 13-for-1 reverse stock split, effective the opening of trading on May 23.
- The company's shareholders had approved an amendment to the fifth amended and restated certificate of incorporation at the company's May 19 annual meeting of stockholders.
- The reverse stock split is expected to bring Sigilon in compliance with Nasdaq's minimum price requirement for continued listing.
- SGTX shares were trading -19.89% pre-market.
- Source: Press Release